… CSF p-tau biomarkers, phosphorylated at threonine-181 and … This study investigated
novel CSF and plasma p-tau … of the assays used in this study. We show the longest form of …

… CSF tau phosphorylated at threonine 181 (p-tau181) is a highly … disease in both plasma
and serum. The blood p-tau181 … The blood p-tau181 assay described in this study could …

… blood tau phosphorylated at threonine 181 (p-tau181) [3,4,5]. Recent researches have
shown promising results for plasma … Taken together, our analysis of longitudinal plasma p-tau181 …

… The lack of early diagnostic biomarkers for selecting prodromal or early-stage patients is one
of the roadblocks in clinical trials. The National Institute on Aging—Alzheimer’s Association …

… of plasma p-tau181 in the Braak I-IV ROI (AUC 0.86, 95%CI 0.80–0.92) which tends to represent
the early stage of tau … data but did not participate in the analysis or writing of this report. …

… Tau species, particularly Tau fragments phosphorylated at threonine 181, these assays …
electrodes for tau protein determination in plasma and brain tissues from Alzheimer patients …

… capabilities of CSF p-tau at threonine 181 (p-tau181) [12] … quantification of phosphorylated
tau at threonine 231 in plasma and … Simoa assay presented in this study measures specific tau …

… Multivariate analysis assessed associations of plasma NfL and p-tau181 levels with AD, …
Neurofilament light (NfL) protein and tau phosphorylated at threonine 181 (p-tau181) are …

… total and phosphorylated tau levels at threonine 181 (pT181) … the presence of amyloidosis
at an early stage in the disease. … could bias the estimation of the phosphorylation ratio at T217 …

… Phosphorylated tau is believed to dissociate from dendrites and form neurofibrillary tangles
in the brains of AD patients. Tau protein phosphorylated at threonine 181 … Simoa assays. To …